David S DeLuca
Overview
Explore the profile of David S DeLuca including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
3494
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Moog M, Hinze C, Bormann T, Aschenbrenner F, Knudsen L, DeLuca D, et al.
J Immunol
. 2022 Feb;
208(5):1259-1271.
PMID: 35149532
Idiopathic pulmonary fibrosis (IPF) is an irreversible, age-related diffuse parenchymal lung disease of poorly defined etiology. Many patients with IPF demonstrate distinctive lymphocytic interstitial infiltrations within remodeled lung tissue with...
12.
Tumpara S, Martinez-Delgado B, Gomez-Mariano G, Liu B, DeLuca D, Korenbaum E, et al.
Front Pharmacol
. 2020 Jul;
11:983.
PMID: 32719598
Human α1-antitrypsin (AAT) is an abundant acute phase glycoprotein expressing anti-protease and immunomodulatory activities, and is used as a biopharmaceutical to treat patients with inherited AAT deficiency. The pleiotropic properties...
13.
Jirmo A, Busse M, Happle C, Skuljec J, Daluge K, Habener A, et al.
Eur J Immunol
. 2020 Mar;
50(7):1019-1033.
PMID: 32142593
IL-17 is associated with different phenotypes of asthma, however, it is not fully elucidated how it influences induction and maintenance of asthma and allergy. In order to determine the role...
14.
Holz O, DeLuca D, Roepcke S, Illig T, Weinberger K, Schudt C, et al.
Int J Chron Obstruct Pulmon Dis
. 2020 Feb;
15:1-13.
PMID: 32021139
Purpose: There is an ongoing demand for easily accessible biomarkers that reflect the physiological and pathophysiological mechanisms of COPD. To test if an exercise challenge could help to identify clinically...
15.
Liu B, Lindner P, Jirmo A, Maus U, Illig T, DeLuca D
BMC Bioinformatics
. 2020 Jan;
21(1):28.
PMID: 31992182
Background: Despite the significant contribution of transcriptomics to the fields of biological and biomedical research, interpreting long lists of significantly differentially expressed genes remains a challenging step in the analysis...
16.
Farutin V, Prodhomme T, McConnell K, Washburn N, Halvey P, Etzel C, et al.
Arthritis Res Ther
. 2019 Oct;
21(1):216.
PMID: 31647025
Background: The goal of this study is to use comprehensive molecular profiling to characterize clinical response to anti-TNF therapy in a real-world setting and identify reproducible markers differentiating good responders...
17.
DeLuca D, Poluzioroviene E, Taminskiene V, Wrenger S, Utkus A, Valiulis A, et al.
Pediatr Pulmonol
. 2019 Jul;
54(9):1474-1478.
PMID: 31298815
Background: There is an association between persistent preschool wheezing phenotypes and school-age asthma. These wheezing/asthma phenotypes likely represent clinical entities having specific genetic risk factors. The SERPINA1 gene encodes α...
18.
Janciauskiene S, DeLuca D, Barrecheguren M, Welte T, Miravitlles M
Arch Bronconeumol (Engl Ed)
. 2019 Jun;
56(2):76-83.
PMID: 31153743
Background: Low plasma level of alpha1-antitrypsin (AAT) is an established risk factor for early-onset chronic obstructive lung disease (COPD). However, less attention is given to the levels of AAT in...
19.
Carlens J, Fuge J, Price T, DeLuca D, Price M, Hansen G, et al.
Pediatr Pulmonol
. 2018 Feb;
53(5):619-627.
PMID: 29393584
Aim: The aim of this study was to evaluate frequency and severity of clearly defined complications of bronchoscopy in children that occur both during and after the procedure, and to...
20.
Wang L, Brooks A, Fan J, Wan Y, Gambe R, Li S, et al.
Cancer Cell
. 2016 Nov;
30(5):750-763.
PMID: 27818134
Mutations in SF3B1, which encodes a spliceosome component, are associated with poor outcome in chronic lymphocytic leukemia (CLL), but how these contribute to CLL progression remains poorly understood. We undertook...